CODX CIK: 1692415

Co-Diagnostics, Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
115
FY22:
92.7
FY23:
62.1
FY24:
32.3
FY25:
13.7
(positive)
Change from FY21 to FY25
millions USD
FY21:
44.9
FY22:
30.4
FY23:
33.2
FY24:
31.3
FY25:
11.0
Total assets
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
123
FY23:
95.3
FY24:
63.6
FY25:
24.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
12.6
FY22:
3.87
FY23:
5.75
FY24:
7.32
FY25:
3.54
(negative)
Change from FY21 to FY25
millions USD
FY21:
13.0
FY22:
4.69
FY23:
3.56
FY24:
2.37
FY25:
0.57
(positive)
Change from FY21 to FY25
millions USD
FY21:
134
FY22:
115
FY23:
86.0
FY24:
53.9
FY25:
20.6
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
160
FY22:
123
FY23:
95.3
FY24:
63.6
FY25:
24.7

All amounts in millions USD Data source:SEC EDGAR